Alternative metalloporphyrins for the treatment of neonatal jaundice

[1] Yao T.C., Stevenson D.K., Advances in the diagnosis and treatment of neonatal hyperbilirubinemia, Clin Perinatol, 22, pp. 741-758, (1995)

[2] Dennery P.A., Seidman D.S., Stevenson D.K., Neonatal hyperbilirubinemia: Pathophysiology, prevention, and treatment, N Engl J Med, 344, pp. 581-590, (2001)

[3] Stevenson D.K., Rodgers P.A., Vreman H.J., The use of metalloporphyrins for the chemoprevention of neonatal jaundice, Am J Dis Child, 143, pp. 353-356, (1989)

[4] Vreman H.J., Verter J., Oh W., Et al., Interlaboratory variability of bilirubin measurements, Clin Chem, 42, pp. 869-873, (1996)

[5] Vreman H.J., Mahoney J.J., Stevenson D.K., Carbon monoxide and carboxyhemoglobin, Adv Pediatr, 42, pp. 303-325, (1995)

[6] Vreman H.J., Wong R.J., Stevenson D.K., Carbon monoxide in breath, blood, and other tissues, Penney DG, pp. 19-60, (2000)

[7] Bhutani V.K., Gourley G.R., Adler S., Kreamer B., Dalin C., Johnson L.H., Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia, Pediatrics, 106, (2000)

[8] Tenhunen R., Marver H.S., Schmid R., The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase, Proc Natl Acad Sci USA, 61, pp. 748-755, (1968)

[9] Maines M.D., Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat, Biochim Biophys Acta, 673, pp. 339-350, (1981)

[10] Marks G.S., Brien J.F., Nakatsu K., McLaughlin B.E., Does carbon monoxide have a physiological function?, Trends Pharmacol Sci, 12, pp. 185-188, (1991)

[1] Yao T.C., Stevenson D.K., Advances in the diagnosis and treatment of neonatal hyperbilirubinemia, Clin Perinatol, 22, pp. 741-758, (1995)

[2] Dennery P.A., Seidman D.S., Stevenson D.K., Neonatal hyperbilirubinemia: Pathophysiology, prevention, and treatment, N Engl J Med, 344, pp. 581-590, (2001)

[3] Stevenson D.K., Rodgers P.A., Vreman H.J., The use of metalloporphyrins for the chemoprevention of neonatal jaundice, Am J Dis Child, 143, pp. 353-356, (1989)

[4] Vreman H.J., Verter J., Oh W., Et al., Interlaboratory variability of bilirubin measurements, Clin Chem, 42, pp. 869-873, (1996)

[5] Vreman H.J., Mahoney J.J., Stevenson D.K., Carbon monoxide and carboxyhemoglobin, Adv Pediatr, 42, pp. 303-325, (1995)

[6] Vreman H.J., Wong R.J., Stevenson D.K., Carbon monoxide in breath, blood, and other tissues, Penney DG, pp. 19-60, (2000)

[7] Bhutani V.K., Gourley G.R., Adler S., Kreamer B., Dalin C., Johnson L.H., Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia, Pediatrics, 106, (2000)

[8] Tenhunen R., Marver H.S., Schmid R., The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase, Proc Natl Acad Sci USA, 61, pp. 748-755, (1968)

[9] Maines M.D., Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat, Biochim Biophys Acta, 673, pp. 339-350, (1981)

[10] Marks G.S., Brien J.F., Nakatsu K., McLaughlin B.E., Does carbon monoxide have a physiological function?, Trends Pharmacol Sci, 12, pp. 185-188, (1991)